Osteoarthritis treatment via the GLP-1-mediated gut-joint axis targets intestinal FXR signaling

Yuanheng Yang^#^{1

2}, Cong Hao^#¹, Tingying Jiao^#^{3

4}, Zidan Yang^#^{5

6

7}, Hui Li^#^{1

5

6}, Yuqing Zhang^{8

9}, Weiya Zhang^{10

11}, Michael Doherty^{10

11}, Chuying Sun¹², Tuo Yang^{5

6

13}, Jiatian Li¹, Jing Wu^{5

6}, Mengjiao Zhang¹², Yilun Wang^{1

5

6}, Dongxing Xie^{1

5

6}, Tingjian Wang^{5

6

14}, Ning Wang^{1

5

6}, Xi Huang^{15

16}, Changjun Li^{5

6

17}, Frank J Gonzalez¹⁸, Jie Wei^{1

5

6

19

20}, Cen Xie^{3

12}, Chao Zeng^{1

5

6

19

21}, Guanghua Lei^{1

5

6

21}

Affiliations

¹ Department of Orthopaedics, Xiangya Hospital, Central South University, Changsha, China.
² Department of Plastic and Cosmetic Surgery, Xiangya Hospital, Central South University, Changsha, China.
³ State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
⁴ Human Phenome Institute, School of Life Sciences, Fudan University, Shanghai, China.
⁵ Key Laboratory of Aging-related Bone and Joint Diseases Prevention and Treatment, Ministry of Education, Xiangya Hospital, Central South University, Changsha, China.
⁶ Hunan Key Laboratory of Joint Degeneration and Injury, Xiangya Hospital, Central South University, Changsha, China.
⁷ Bioinformatics Center, Xiangya Hospital, Central South University, Changsha, China.
⁸ Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
⁹ The Mongan Institute, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
¹⁰ Academic Rheumatology, School of Medicine, University of Nottingham, Nottingham, UK.
¹¹ Pain Centre Versus Arthritis UK, Nottingham, UK.
¹² School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, China.
¹³ Health Management Center, Xiangya Hospital, Central South University, Changsha, China.
¹⁴ Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, China.
¹⁵ Developmental and Stem Cell Biology Program, The Hospital for Sick Children, Toronto, ON, Canada.
¹⁶ Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.
¹⁷ Department of Endocrinology, Endocrinology Research Center, Xiangya Hospital, Central South University, Changsha, China.
¹⁸ Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
¹⁹ Department of Epidemiology and Health Statistics, Xiangya School of Public Health, Central South University, Changsha, China.
²⁰ Bioinformatics Center, Furong Laboratory, Changsha, China.
²¹ National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China.

^# Contributed equally.

PMID: 40179178
DOI: 10.1126/science.adt0548

Osteoarthritis treatment via the GLP-1-mediated gut-joint axis targets intestinal FXR signaling

Yuanheng Yang et al. Science. 2025.

. 2025 Apr 4;388(6742):eadt0548.

doi: 10.1126/science.adt0548. Epub 2025 Apr 4.

Authors

Affiliations

¹ Department of Orthopaedics, Xiangya Hospital, Central South University, Changsha, China.
² Department of Plastic and Cosmetic Surgery, Xiangya Hospital, Central South University, Changsha, China.
³ State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
⁴ Human Phenome Institute, School of Life Sciences, Fudan University, Shanghai, China.
⁵ Key Laboratory of Aging-related Bone and Joint Diseases Prevention and Treatment, Ministry of Education, Xiangya Hospital, Central South University, Changsha, China.
⁶ Hunan Key Laboratory of Joint Degeneration and Injury, Xiangya Hospital, Central South University, Changsha, China.
⁷ Bioinformatics Center, Xiangya Hospital, Central South University, Changsha, China.
⁸ Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
⁹ The Mongan Institute, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
¹⁰ Academic Rheumatology, School of Medicine, University of Nottingham, Nottingham, UK.
¹¹ Pain Centre Versus Arthritis UK, Nottingham, UK.
¹² School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, China.
¹³ Health Management Center, Xiangya Hospital, Central South University, Changsha, China.
¹⁴ Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, China.
¹⁵ Developmental and Stem Cell Biology Program, The Hospital for Sick Children, Toronto, ON, Canada.
¹⁶ Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.
¹⁷ Department of Endocrinology, Endocrinology Research Center, Xiangya Hospital, Central South University, Changsha, China.
¹⁸ Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
¹⁹ Department of Epidemiology and Health Statistics, Xiangya School of Public Health, Central South University, Changsha, China.
²⁰ Bioinformatics Center, Furong Laboratory, Changsha, China.
²¹ National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China.

^# Contributed equally.

PMID: 40179178
DOI: 10.1126/science.adt0548

Abstract

Whether a gut-joint axis exists to regulate osteoarthritis is unknown. In two independent cohorts, we identified altered microbial bile acid metabolism with reduced glycoursodeoxycholic acid (GUDCA) in osteoarthritis. Suppressing farnesoid X receptor (FXR)-the receptor of GUDCA-alleviated osteoarthritis through intestine-secreted glucagon-like peptide 1 (GLP-1) in mice. GLP-1 receptor blockade attenuated these effects, whereas GLP-1 receptor activation mitigated osteoarthritis. Osteoarthritis patients exhibited a lower relative abundance of Clostridium bolteae, which promoted the formation of ursodeoxycholic acid (UDCA), a precursor of GUDCA. Treatment with C. bolteae and Food and Drug Administration-approved UDCA alleviated osteoarthritis through the gut FXR-joint GLP-1 axis in mice. UDCA use was associated with lower risk of osteoarthritis-related joint replacement in humans. These findings suggest that orchestrating the gut microbiota-GUDCA-intestinal FXR-GLP-1-joint pathway offers a potential strategy for osteoarthritis treatment.

PubMed Disclaimer

References

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information
Molecular Biology Databases
- Mouse Genome Informatics (MGI)

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Osteoarthritis treatment via the GLP-1-mediated gut-joint axis targets intestinal FXR signaling

Affiliations

Osteoarthritis treatment via the GLP-1-mediated gut-joint axis targets intestinal FXR signaling

Authors

Affiliations

Abstract

References

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Molecular Biology Databases